Erythema annulare centrifugum induced by COVID‐19 vaccination. (25th November 2021)

• Record Type: Journal Article
• Authors: Kim, J. C.; Lee, S. Y.; Kang, S. Y.; Kim, H. O.; Park, C. W.; Chung, B. Y.
• Is Part Of: Clinical and experimental dermatology. Volume 47:Number 3(2022)
• Page Start: 591
• Page End: 592
• Publication Date: 2021-11-25
• Subjects: Skin -- Diseases -- Periodicals; 616.5
• DOI: 10.1111/ced.15002
• Languages: English
• ISSNs: 0307-6938

Abstract

Abstract : With the expansion of the COVID‐19 vaccination drive, an increasing number of adverse effects are surfacing. A 74‐year‐old woman presented with multiple erythematous and itchy patches on several sites. She had no relevant medical history, apart from the first AZD1222 vaccination 1 month previously. Microscopically, epidermal changes, including mild spongiosis and parakeratosis, were observed. Tight perivascular lymphocytic infiltration (coat‐sleeve pattern) was also observed in the dermis. The final diagnosis was erythema annulare centrifugum (EAC) induced by SARS‐CoV‐2 vaccination. Based on this report, dermatologists should be aware of the possibility of EAC from the AZD1222 vaccination.